07/21/2025
11:03 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
11:36 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
1:47 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
5:15 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
7:42 AM | Provectus Biopharmaceuticals (Filer)
| Form DEFA14A | |
06/18/2025
7:43 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
5:24 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
3:32 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
1:24 PM | Provectus Biopharmaceuticals (Filer)
| Form 10-K/A | |
05/15/2025
8:09 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
8:46 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PVCT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/05/2025
5:14 AM | Provectus Biopharmaceuticals (Filer)
| Form ARS | |
04/30/2025
10:38 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
1:22 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
12:35 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2025
2:13 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
4:06 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
6:20 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
7:37 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
10:47 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:26 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
10:10 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
12:37 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:13 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
2:57 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
12:31 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
3:33 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
8:30 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
8:00 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
6:45 PM | Pershing Edward (Filed by)
Provectus Biopharmaceuticals (Subject)
| Form SC 13D/A | |
12/02/2024
6:48 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:12 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
7:00 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
11:31 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:58 PM | Bailey Webster (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
7:01 PM | Lacey John III (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
7:06 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
5:56 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
5:58 PM | Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
4:21 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
8:54 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Critical AI announcement set to ignite AI 2.0 (Ad) I just put together an urgent new presentation that you need to see right away.
In short: I believe we are mere days away from a critical announcement from a key tech leader…
One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.  Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
08/27/2024
10:15 AM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
2:06 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:23 PM | Morris Jeffrey Allen (Filed by)
Provectus Biopharmaceuticals (Subject)
| Form SC 13G | |
08/14/2024
6:19 PM | Morris Jeffrey Allen (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
12:21 PM | Provectus Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
2:31 PM | Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
